27 Nisan 2012 Cuma

Health Tip: When Seniors Are Malnourished: MedlinePlus

To contact us Click HERE
Health Tip: When Seniors Are Malnourished: MedlinePlus


Health Tip: When Seniors Are Malnourished

Symptoms may include lack of energy
By Diana Kohnle Wednesday, April 25, 2012 Related MedlinePlus Page
  • Nutrition for Seniors
(HealthDay News) -- Older people are particularly prone to malnutrition because of chronic disease, having to live on a fixed income, or the unmet need to provide their aging bodies with the proper vitamins and nutrients.
Some 3.7 million American seniors are malnourished, the American Academy of Family Physicians estimates. The academy mentions some of the potential side effects:
  • Feeling fatigued.
  • Losing weight without trying.
  • Losing muscle strength.
  • Feeling depressed.
  • Having memory loss.
  • Getting sick frequently.
  • Developing anemia.
HealthDay Copyright (c) 2012 HealthDay. All rights reserved.
More Health News on:
Nutrition for Seniors

Mixed evidence on acupuncture for irritable bowels: MedlinePlus

To contact us Click HERE
Mixed evidence on acupuncture for irritable bowels: MedlinePlus


Mixed evidence on acupuncture for irritable bowels


Wednesday, April 25, 2012 Related MedlinePlus Pages
  • Acupuncture
  • Irritable Bowel Syndrome
By Amy Norton
NEW YORK (Reuters Health) - The research on whether acupuncture helps ease irritable bowel syndrome has so far been a mixed bag, according to a new review of past clinical trials.

The review, published in the American Journal of Gastroenterology, found that in some trials, acupuncture seemed to work better than certain medications for irritable bowel syndrome, or IBS.

Yet in others, acupuncture was no better than a "sham" version of acupuncture used for comparison.
"It's difficult to interpret the results of the review," said lead researcher Eric Manheimer, of the Center for Integrative Medicine at the University of Maryland School of Medicine.

For now, he told Reuters Health, "I think the evidence is equivocal."

IBS is a digestive disorder that causes repeated bouts of abdominal cramps, bloating, and either diarrhea or constipation. It's different from the similar-sounding inflammatory bowel disease -- an umbrella term for ulcerative colitis and Crohn's disease, two more-serious digestive disorders that damage the lining of the colon.

In many cases, IBS can be managed with diet changes, along with anti-diarrheal medication or, for constipation, laxatives or fiber supplements.

But people with tougher-to-treat IBS may need more. There are a few drugs for the condition -- including alosetron (Lotronex), which works on nerves to relax the colon, and lubiprostone (Amitiza), which helps with constipation.

Doctors sometimes also prescribe low-dose antidepressants, anti-anxiety medications or drugs called antispasmodics, which may help with abdominal pain.

But those drugs are often limited in their effectiveness, and can have side effects.


PLACEBO EFFECT?
So researchers are looking at different non-drug options. Two -- namely, cognitive behavioral therapy and hypnosis -- have proven effective for some people in clinical trials.

A fairly small number of studies have begun looking at acupuncture. And so far, Manheimer's team found, those trials have yielded mixed results.

In their review, the researchers found five clinical trials that tested "true" acupuncture against a sham version of the procedure.

Some studies use sham procedures to try to account for the "placebo effect" -- where people feel better simply because they expect a treatment to work.

Overall, Manheimer's team found, none of the five trials showed that real acupuncture was any better than the fake version when it came to improving patients' ratings of their symptoms or quality of life.

On the other hand, five trials done in China did find that patients reported bigger gains from acupuncture when it was tested against certain medications -- which included certain anti-diarrheal, antispasmodic and anti-inflammatory drugs.

But there are limitations to both types of studies, Manheimer said.

With the trials that pitted acupuncture against drugs, the patients were recruited at hospitals for traditional Chinese medicine.

"So it's possible that patients' expectations played a role" in acupuncture's higher success odds, Manheimer explained. That is, many may have believed acupuncture to be effective, or had a preference for it over medication.

With the sham-acupuncture trials, the study groups tended to be small, which may have limited their ability to pick up small benefits of true acupuncture, the researchers say.

There's also debate over what makes for a good sham version of acupuncture. In some studies, it may involve inserting needles in the skin at sites that are not considered acupuncture points according to traditional Chinese medicine.

In others, it means using a dull needle that doesn't penetrate the skin.

"It's not clear that they (shams) are all inert," Manheimer said.

That means some sham acupuncture tactics may have biological effects that are close to the real thing. No one is sure how acupuncture works, but some research suggests the needle stimulation triggers the release of pain- and inflammation-fighting chemicals in the body -- even if the acupuncture doesn't strictly follow traditional principles.

Of the five trials in this review, two were judged as having sham acupuncture that might have had real biological effects. But that doesn't explain why the other three studies showed no benefit, the researchers say.


NOT A ‘GO-TO' TREATMENT
In the future, Manheimer said it might be helpful to do trials that compare acupuncture against other treatments, but do it with a more general population of IBS sufferers than the Chinese studies used.
It would also be a good idea, he said, to measure patients' expectations going into the study. That way, researchers can look at whether people who expected to improve were more likely to report benefits from acupuncture.

"This is an interesting study," said Jeffrey M. Lackner, an associate professor at the University at Buffalo School of Medicine in New York, who was not involved in the work.

In the U.S., he noted, acupuncture would not be considered a "go-to" IBS treatment right now anyway.
As far as non-drug options, cognitive behavioral therapy (CBT) seems to have the best research evidence to back it up, according to Lackner. CBT is a form of "talk therapy" that helps people recognize the unhealthy thought patterns and behaviors that feed their symptoms, and gives them practical ways to manage them.
The problem with CBT, though, is availability. "There are not a lot of therapists out there who can do it," Lackner told Reuters Health.

"We really need to start developing IBS treatments that are more easily disseminated," he said. That could mean "self-help materials," like books or CDs, that teach people CBT principles.

As for acupuncture, Manheimer said that if people did want to give it a shot, safety and cost would be the other considerations.

Acupuncture is generally considered safe, with side effects like bruising at the needle site. The cost can vary widely, but a session would typically start at around $100.

And many patients, Manheimer noted, may have to pay out of pocket.


SOURCE: http://bit.ly/IoaQnA American Journal of Gastroenterology, online April 10, 2012.
Reuters Health (c) Copyright Thomson Reuters 2012. Check for restrictions at: http://about.reuters.com/fulllegal.asp
More Health News on:
Acupuncture
Irritable Bowel Syndrome

Health Tip: Stress Fracture of the Foot: MedlinePlus

To contact us Click HERE
Health Tip: Stress Fracture of the Foot: MedlinePlus


Health Tip: Stress Fracture of the Foot

Possible symptoms of this overuse injury
By Diana Kohnle Wednesday, April 25, 2012 Related MedlinePlus Page
  • Foot Injuries and Disorders
(HealthDay News) -- The bones of your feet are designed to absorb the weight and energy of the rest of your moving body. But when nearby muscles are overused and can no longer absorb the shock of running, jogging or playing sports, for example, your foot may develop a stress fracture.
The American Academy of Orthopaedic Surgeons says possible warning signs of stress fracture of the foot include:
  • Pain that gradually worsens over time, increasing during weight-bearing activities and improving during rest.
  • Swelling at the top of the foot and outside the ankle.
  • Tenderness or soreness.
  • Bruising.
HealthDay Copyright (c) 2012 HealthDay. All rights reserved.
More Health News on:
Foot Injuries and Disorders

MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes

To contact us Click HERE
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes

  • Original Research

MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes

  1. Victor J. Dzau
+ Author Affiliations
  1. From Duke Cardiovascular Research Center, Duke University Medical Center, Durham, NC (T.M.J., B.E., E.A.F., L.Z., J.A.P., Z.Z., P.R., M.M., V.J.D.); Mandel Center for Hypertension and Atherosclerosis Research, Duke University Medical Center, Durham, NC (T.M.J., B.E., L.Z., J.A.P., Z.Z., M.M., V.J.D.); Ion Channel Research Group, Duke University Medical Center, Durham, NC (E.A.F., P.R.); Sarah Steadman Nutrition and Metabolism Center, Duke University School of Medicine, Durham, NC (P.R.); and the Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC (K.P.).
  1. Correspondence to Victor J. Dzau, MD, and Maria Mirotsou PhD, DUMC Box 3701, Durham, NC 27710. E-mail victor.dzau@duke.edu or maria.mirotsou@duke.edu

Abstract

Rationale: Repopulation of the injured heart with new, functional cardiomyocytes remains a daunting challenge for cardiac regenerative medicine. An ideal therapeutic approach would involve an effective method at achieving direct conversion of injured areas to functional tissue in situ. Objective: The aim of this study was to develop a strategy that identified and evaluated the potential of specific micro (mi)RNAs capable of inducing reprogramming of cardiac fibroblasts directly to cardiomyocytes in vitro and in vivo. Methods and Results: Using a combinatorial strategy, we identified a combination of miRNAs 1, 133, 208, and 499 capable of inducing direct cellular reprogramming of fibroblasts to cardiomyocyte-like cells in vitro. Detailed studies of the reprogrammed cells demonstrated that a single transient transfection of the miRNAs can direct a switch in cell fate as documented by expression of mature cardiomyocyte markers, sarcomeric organization, and exhibition of spontaneous calcium flux characteristic of a cardiomyocyte-like phenotype. Interestingly, we also found that miRNA-mediated reprogramming was enhanced 10-fold on JAK inhibitor I treatment. Importantly, administration of miRNAs into ischemic mouse myocardium resulted in evidence of direct conversion of cardiac fibroblasts to cardiomyocytes in situ. Genetic tracing analysis using Fsp1Cre-traced fibroblasts from both cardiac and noncardiac cell sources strongly suggests that induced cells are most likely of fibroblastic origin. Conclusions: The findings from this study provide proof-of-concept that miRNAs have the capability of directly converting fibroblasts to a cardiomyocyte-like phenotype in vitro. Also of significance is that this is the first report of direct cardiac reprogramming in vivo. Our approach may have broad and important implications for therapeutic tissue regeneration in general. Key Words:
  • direct reprogramming
  • cardiac differentiation
  • microRNAs
  • tissue regeneration
  • Received March 9, 2012.
  • Revision received March 26, 2012.
  • Accepted March 29, 2012.

Neuromyelitis optica - Genetics Home Reference

To contact us Click HERE

full-text ►
Neuromyelitis optica - Genetics Home Reference



Neuromyelitis optica

On this page:
  • Description
  • Genetic changes
  • Inheritance
  • Diagnosis
  • Additional information
  • Other names
  • Glossary definitions
Reviewed April 2012

What is neuromyelitis optica?

Neuromyelitis optica is an autoimmune disorder that affects the nerves of the eyes and the central nervous system, which includes the brain and spinal cord. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In neuromyelitis optica, the autoimmune attack causes inflammation of the nerves, and the resulting damage leads to the signs and symptoms of the condition.
Neuromyelitis optica is characterized by optic neuritis, which is inflammation of the nerve that carries information from the eye to the brain (optic nerve). Optic neuritis causes eye pain and vision loss, which can occur in one or both eyes.
Neuromyelitis optica is also characterized by transverse myelitis, which is inflammation of the spinal cord. The inflammation associated with transverse myelitis damages the spinal cord, causing a lesion that often extends the length of three or more bones of the spine (vertebrae). In addition, myelin, which is the covering that protects nerves and promotes the efficient transmission of nerve impulses, can be damaged. Transverse myelitis causes weakness, numbness, and paralysis of the arms and legs. Other effects of spinal cord damage can include disturbances in sensations, loss of bladder and bowel control, uncontrollable hiccupping, and nausea. In addition, muscle weakness may make breathing difficult and can cause life-threatening respiratory  failure in people with neuromyelitis optica.
There are two forms of neuromyelitis optica, the relapsing form and the monophasic form. The relapsing form is most common. This form is characterized by recurrent episodes of optic neuritis and transverse myelitis. These episodes can be months or years apart, and there is usually partial recovery between episodes. However, most affected individuals eventually develop permanent muscle weakness and vision impairment that persist even between episodes. For unknown reasons, approximately four times more women than men have the relapsing form. The monophasic form, which is less common, causes a single episode of neuromyelitis optica that can last several months. People with this form of the condition can also have lasting muscle weakness or paralysis and vision loss. This form affects men and women equally. The onset of either form of neuromyelitis optica can occur anytime from childhood to adulthood, although the condition most frequently begins in childhood or in a person's forties.
Approximately one-quarter of individuals with neuromyelitis optica have signs or symptoms of another autoimmune disorder such as myasthenia gravis, systemic lupus erythematosus, or Sjögren syndrome. Some  scientists believe that a condition described in Japanese patients as optic-spinal multiple sclerosis (or opticospinal multiple sclerosis) that affects the nerves of the eyes and central nervous system is the same as neuromyelitis optica.

How common is neuromyelitis optica?

Neuromyelitis optica affects approximately 1 to 2 per 100,000 people worldwide. Women are affected by this condition more frequently than men.

What genes are related to neuromyelitis optica?

No genes associated with neuromyelitis optica have been identified. However, approximately 3 percent of people with this condition have a family member who is also affected, which indicates that there may be one or more genetic changes that increase susceptibility. It is thought that the inheritance of this condition is complex and that many environmental and genetic factors are involved in the development of the condition.
The aquaporin-4 protein (AQP4), a normal protein in the body, plays a role in neuromyelitis optica. The aquaporin-4 protein is found in several body systems but is most abundant in tissues of the central nervous system. Approximately 70 percent of people with this disorder produce an immune protein called an antibody that attaches (binds) to the aquaporin-4 protein. Antibodies normally bind to specific foreign particles and germs, marking them for destruction, but the antibody in people with neuromyelitis optica attacks a normal human protein; this type of antibody is called an autoantibody. The autoantibody in this condition is called NMO-IgG or anti-AQP4.
The binding of the NMO-IgG autoantibody to the aquaporin-4 protein turns on (activates) the complement system, which is a group of immune system proteins that work together to destroy pathogens, trigger inflammation, and remove debris from cells and tissues. Complement activation leads to the inflammation of the optic nerve and spinal cord that is characteristic of neuromyelitis optica, resulting in the signs and symptoms of the condition.
The levels of the NMO-IgG autoantibody are high during episodes of neuromyelitis optica, and the levels decrease between episodes with treatment of the disorder. However, it is unclear what triggers episodes to begin or end.